Muga R - Search Results

1

Impact of hepatitis C virus infection on the risk of death of alcohol-dependent patients.

Fuster D, Sanvisens A, Bolao F, Serra I, Rivas I, Tor J, Muga R. Fuster D, et al. Among authors: muga r. J Viral Hepat. 2015 Jan;22(1):18-24. doi: 10.1111/jvh.12290. Epub 2014 Aug 18. J Viral Hepat. 2015. PMID: 25131721

2

Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.

Sanvisens A, Serra I, Tural C, Tor J, Ojanguren I, Barluenga E, Rey-Joly C, Clotet B, Muga R. Sanvisens A, et al. Among authors: muga r. J Viral Hepat. 2009 Jul;16(7):513-8. doi: 10.1111/j.1365-2893.2009.01103.x. Epub 2009 Feb 5. J Viral Hepat. 2009. PMID: 19200132

3

Estimated liver fibrosis and its impact on all-cause mortality of HCV-monoinfected and HCV/HIV-coinfected drug users.

Sanvisens A, Fuster D, Serra I, Tor J, Tural C, Rey-Joly C, Muga R. Sanvisens A, et al. Among authors: muga r. Curr HIV Res. 2011 Jun;9(4):256-62. doi: 10.2174/157016211796320298. Curr HIV Res. 2011. PMID: 21675942

4

Initiation, changes in use and effectiveness of highly active anti-retroviral therapy in a cohort of injecting drug users.

Egea JM, Muga R, Sirera G, Clotet B, Tor J, Ardèvol M, Rey-Joly C, Muñoz A. Egea JM, et al. Among authors: muga r. Epidemiol Infect. 2002 Oct;129(2):325-33. doi: 10.1017/s0950268802007495. Epidemiol Infect. 2002. PMID: 12403108 Free PMC article.

5

Prospective evaluation of latent tuberculosis with interferon-gamma release assays in drug and alcohol abusers.

Rivas I, Latorre I, Sanvisens A, Domínguez J, Tor J, Prat C, Rey-Joly C, Muga R. Rivas I, et al. Among authors: muga r. Epidemiol Infect. 2009 Sep;137(9):1342-7. doi: 10.1017/S0950268809002131. Epub 2009 Feb 26. Epidemiol Infect. 2009. PMID: 19243652

6

Use of highly active antiretroviral therapy is increasing in HIV positive severe drug users.

Vallecillo G, Sanvisens A, Martinez E, Torrens M, Bolao F, Tor J, Muga R. Vallecillo G, et al. Among authors: muga r. Curr HIV Res. 2010 Dec;8(8):641-8. doi: 10.2174/157016210794088272. Curr HIV Res. 2010. PMID: 21187006

7

Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline.

Sanmartín R, Tor J, Sanvisens A, López JJ, Jou A, Muga R, Ojanguren I, Barluenga E, Videla S, Planas R, Clotet B, Tural C. Sanmartín R, et al. Among authors: muga r. HIV Med. 2014 Apr;15(4):203-12. doi: 10.1111/hiv.12105. Epub 2013 Nov 19. HIV Med. 2014. PMID: 24245909 Free article.

8

Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV.

Tor J, Llibre JM, Carbonell M, Muga R, Ribera A, Soriano V, Clotet B, Sabriá M, Foz M. Tor J, et al. Among authors: muga r. BMJ. 1990 Nov 17;301(6761):1130-3. doi: 10.1136/bmj.301.6761.1130. BMJ. 1990. PMID: 2174705 Free PMC article.

9

[Mortality in a cohort of intravenous drug users before the introduction of potent HIV therapy].

Muga R, Egea JM, Navío M, Sirera G, Vall M, Tor J. Muga R, et al. Med Clin (Barc). 1999 May 29;112(19):721-5. Med Clin (Barc). 1999. PMID: 10394568 Spanish.

10

Mortality of HIV-positive and HIV-negative heroin abusers as a function of duration of injecting drug use.

Muga R, Roca J, Egea JM, Tor J, Sirera G, Rey-Joly C, Muñoz A. Muga R, et al. J Acquir Immune Defic Syndr. 2000 Apr 1;23(4):332-8. doi: 10.1097/00126334-200004010-00009. J Acquir Immune Defic Syndr. 2000. PMID: 10836756

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

266 results

Search Page

Filters